Role of Systemic Treatment for Advanced/Metastatic Gastric Carcinoma in the Third-Line Setting: A Bayesian Network Analysis

Background: Increasing evidences from phase II or III trials have proved that salvage systematic therapy, including chemotherapy, target therapy, or checkpoint inhibitor therapy can prolong survival in patients who do not succeed with second line therapy, yet there are no guidelines for the optimum...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Wen-Tao, Zhou, Su-Na, Pan, Meng-Xian, Luo, Qiu-Yun, Zhang, Lin, Yang, Da-Jun, Qiu, Miaozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191061/
https://www.ncbi.nlm.nih.gov/pubmed/32391262
http://dx.doi.org/10.3389/fonc.2020.00513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191061/
https://www.ncbi.nlm.nih.gov/pubmed/32391262
http://dx.doi.org/10.3389/fonc.2020.00513

Ejemplares similares